January 16, 2025
January 16, 2025
FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension
January 15, 2025
Higher Surgeon HRV Linked to Better Outcomes
January 15, 2025
Metformin Exposure Shows Non-Melanoma Skin Cancer Associations
January 15, 2025
Hydrophobic, Chlorhexidine, vs. Standard PICCs
January 15, 2025
CMR-PCWP Correlates with Heart Failure Biomarkers
Latest Headlines
View More
January 16, 2025
Exercise Therapy as Candidate Anticancer Strategy
January 16, 2025
Study Questions Urokinase's Role in Minor Stroke Care
January 16, 2025
FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension
January 15, 2025
Higher Surgeon HRV Linked to Better Outcomes
January 15, 2025
Bertagnolli to Exit NIH Director Role
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
Conference Coverage
38th Annual Miami Breast Cancer Conference
October 13, 2021
Novel HER2-Targeted Therapies Pose Sequencing Challenges
August 02, 2021
Breast Cancer in 2030: Predictions From a Breast Cancer Luminary
American Heart Association’s Hypertension Scientific Sessions 2024
September 09, 2024
Bariatric Surgery Outperformed Meds for Hypertension Control
American Academy of Ophthalmology annual meeting
September 01, 2024
An Update on SLT Clinical Trials
October 01, 2024
Fellow Eye Dosing of Gene Therapy Found Safe, Effective
Clinical Guidelines
View More
December 23, 2024
ACC Issues New Post-Stroke Monitoring Guidelines
July 06, 2023
Faculty Publications: June 29-July 6
Commentary & Perspectives
View More
FDA & Government News
View More
January 16, 2025
FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension
January 15, 2025
Bertagnolli to Exit NIH Director Role
January 15, 2025
FDA Proposes Nicotine Limits for Tobacco
Business Management
View More
